Cargando…
GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Ch...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679712/ https://www.ncbi.nlm.nih.gov/pubmed/19366456 http://dx.doi.org/10.1186/1479-5876-7-26 |
_version_ | 1782166911440650240 |
---|---|
author | Dai, Pu Yu, Fei Han, Bing Liu, Xuezhong Wang, Guojian Li, Qi Yuan, Yongyi Liu, Xin Huang, Deliang Kang, Dongyang Zhang, Xin Yuan, Huijun Yao, Kun Hao, Jinsheng He, Jia He, Yong Wang, Youqin Ye, Qing Yu, Youjun Lin, Hongyan Liu, Lijia Deng, Wei Zhu, Xiuhui You, Yiwen Cui, Jinghong Hou, Nongsheng Xu, Xuehai Zhang, Jin Tang, Liang Song, Rendong Lin, Yongjun Sun, Shuanzhu Zhang, Ruining Wu, Hao Ma, Yuebing Zhu, Shanxiang Wu, Bai-lin Han, Dongyi Wong, Lee-Jun C |
author_facet | Dai, Pu Yu, Fei Han, Bing Liu, Xuezhong Wang, Guojian Li, Qi Yuan, Yongyi Liu, Xin Huang, Deliang Kang, Dongyang Zhang, Xin Yuan, Huijun Yao, Kun Hao, Jinsheng He, Jia He, Yong Wang, Youqin Ye, Qing Yu, Youjun Lin, Hongyan Liu, Lijia Deng, Wei Zhu, Xiuhui You, Yiwen Cui, Jinghong Hou, Nongsheng Xu, Xuehai Zhang, Jin Tang, Liang Song, Rendong Lin, Yongjun Sun, Shuanzhu Zhang, Ruining Wu, Hao Ma, Yuebing Zhu, Shanxiang Wu, Bai-lin Han, Dongyi Wong, Lee-Jun C |
author_sort | Dai, Pu |
collection | PubMed |
description | BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Chinese population, the coding region of the GJB2 gene from 2063 unrelated patients with NSHI was PCR amplified and sequenced. RESULTS: A total of 23 pathogenic mutations were identified. Among them, five (p.W3X, c.99delT, c.155_c.158delTCTG, c.512_c.513insAACG, and p.Y152X) are novel. Three hundred and seven patients carry two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carry only one mutant allele. Thus, GJB2 mutations account for 17.9% of the mutant alleles in 2063 NSHI patients. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations. The four prevalent mutations; c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG, account for 88.0% of all mutantalleles identified. The frequency of GJB2 mutations (alleles) varies from 4% to 30.4% among different regions of China. It also varies among different sub-ethnic groups. CONCLUSION: In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary. |
format | Text |
id | pubmed-2679712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26797122009-05-09 GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment Dai, Pu Yu, Fei Han, Bing Liu, Xuezhong Wang, Guojian Li, Qi Yuan, Yongyi Liu, Xin Huang, Deliang Kang, Dongyang Zhang, Xin Yuan, Huijun Yao, Kun Hao, Jinsheng He, Jia He, Yong Wang, Youqin Ye, Qing Yu, Youjun Lin, Hongyan Liu, Lijia Deng, Wei Zhu, Xiuhui You, Yiwen Cui, Jinghong Hou, Nongsheng Xu, Xuehai Zhang, Jin Tang, Liang Song, Rendong Lin, Yongjun Sun, Shuanzhu Zhang, Ruining Wu, Hao Ma, Yuebing Zhu, Shanxiang Wu, Bai-lin Han, Dongyi Wong, Lee-Jun C J Transl Med Research BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Chinese population, the coding region of the GJB2 gene from 2063 unrelated patients with NSHI was PCR amplified and sequenced. RESULTS: A total of 23 pathogenic mutations were identified. Among them, five (p.W3X, c.99delT, c.155_c.158delTCTG, c.512_c.513insAACG, and p.Y152X) are novel. Three hundred and seven patients carry two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carry only one mutant allele. Thus, GJB2 mutations account for 17.9% of the mutant alleles in 2063 NSHI patients. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations. The four prevalent mutations; c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG, account for 88.0% of all mutantalleles identified. The frequency of GJB2 mutations (alleles) varies from 4% to 30.4% among different regions of China. It also varies among different sub-ethnic groups. CONCLUSION: In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary. BioMed Central 2009-04-14 /pmc/articles/PMC2679712/ /pubmed/19366456 http://dx.doi.org/10.1186/1479-5876-7-26 Text en Copyright © 2009 Dai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Dai, Pu Yu, Fei Han, Bing Liu, Xuezhong Wang, Guojian Li, Qi Yuan, Yongyi Liu, Xin Huang, Deliang Kang, Dongyang Zhang, Xin Yuan, Huijun Yao, Kun Hao, Jinsheng He, Jia He, Yong Wang, Youqin Ye, Qing Yu, Youjun Lin, Hongyan Liu, Lijia Deng, Wei Zhu, Xiuhui You, Yiwen Cui, Jinghong Hou, Nongsheng Xu, Xuehai Zhang, Jin Tang, Liang Song, Rendong Lin, Yongjun Sun, Shuanzhu Zhang, Ruining Wu, Hao Ma, Yuebing Zhu, Shanxiang Wu, Bai-lin Han, Dongyi Wong, Lee-Jun C GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title | GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title_full | GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title_fullStr | GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title_full_unstemmed | GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title_short | GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment |
title_sort | gjb2 mutation spectrum in 2063 chinese patients with nonsyndromic hearing impairment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679712/ https://www.ncbi.nlm.nih.gov/pubmed/19366456 http://dx.doi.org/10.1186/1479-5876-7-26 |
work_keys_str_mv | AT daipu gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yufei gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT hanbing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT liuxuezhong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT wangguojian gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT liqi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yuanyongyi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT liuxin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT huangdeliang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT kangdongyang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT zhangxin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yuanhuijun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yaokun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT haojinsheng gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT hejia gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT heyong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT wangyouqin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yeqing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT yuyoujun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT linhongyan gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT liulijia gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT dengwei gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT zhuxiuhui gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT youyiwen gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT cuijinghong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT hounongsheng gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT xuxuehai gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT zhangjin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT tangliang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT songrendong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT linyongjun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT sunshuanzhu gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT zhangruining gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT wuhao gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT mayuebing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT zhushanxiang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT wubailin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT handongyi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment AT wongleejunc gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment |